ESMO Events 2026

Meetingsopens in new tab/window | ESMOopens in new tab/window

Welcome to our ESMO Virtual Congress site where we showcase the very best from ESMO's flagship portfolio.

Below a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the theme of the meeting:

ESMO Molecular Analysis for Precision Oncology Congress 2026opens in new tab/window

Building on the momentum of previous editions, the congress will provide a platform to share advances in cancer research, strengthen connections across disciplines, and accelerate the translation of molecular insights into clinical practice.

Through keynote sessions, discussions, and networking opportunities, participants will engage with the evolving landscape of precision oncology and its impact on patient care worldwide.

Below a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the themes of the meeting.

Annals of Oncology

• Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small-cell lung cancer: 7-year update from the phase III CROWN studyopens in new tab/window A.T. Shaw, B.J. Solomon, E. Felip, T.M. Bauer, G. Liu, Y. Goto, Y.-L. Wu, R.A. Soo, J. Mazieres, D.-W. Kim, I.-M. Wang, J. Paolini, A. Polli, N. Rifi, F. Toffalorio, T.S.K. Mok

• Preclinical characterization and phase I results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumorsopens in new tab/window D.Y. Ruan, S.Y. Lin, J.J. Huang, Y.H. Li, N. Li, X.J. Qu, X.B. Du, Y.M. Yin, Z.Y. Yuan, Y.X. Shi, F. Xu, X. An, R.X. Hong, W. Xia, C. Xue, X.W. Bi, K.K. Jiang, Q.F. Zheng, Y.Q. Zhang, J.J. Peng, Z.Y. Liu, H.H. Xiong, A.L. Suo, R.B. Lin, S. Zhang, S.N. Tang, Y. Yu, X. Li, X. Wang, X. Tian, P. Lv, C. Shen, L.G. Lou, L. Wang, Z.P. Zhang, T.J. Xu, T.X. Chen, S.S. Wang, R.H. Xu

ESMO Open

• Real-world overall survival improvements in metastatic urothelial carcinoma across three key therapeutic temporal periodsopens in new tab/window A. Cigliola, B.A. Maiorano, G. Guandalini, V. Tateo, C. Mercinelli, M. Piacentini, A. Bertini, N. Dizman, S.K. Pal, S. Gupta, P. Grivas, A. Kamat, P.E. Spiess, N. Agarwal, A. Briganti, F. Montorsi, A. Necchi

• Mapping the HER-family landscape in advanced urothelial carcinomaopens in new tab/window A. Moradi, K. Shah, A. Tripathi

Immuno-Oncology and Technology

• Management of systemic lupus erythematosus and antiphospholipid syndrome during CAR-T therapy: insights from two clinical casesopens in new tab/window C. Normand, S. Almaz, R. Stadelmann, M. Goodyer, B. Navarro, A.I. Martin Quesada, A. Mulvey, P. Szturz, B. Gentner, L. Trueb, C. Arber, E. Ghisoni, M. Le Moine

• Corticosteroid exposure, tapering, and survival in immune-related colitis: a 10-year real-world melanoma cohortopens in new tab/window S.K. Petersen, S. Madley, J. Kjeldsen, L. Bastholt, C. Brink, C.H. Ruhlmann

ESMO Gastrointestinal Oncology

• Neoadjuvant immunotherapy followed by surgery versus non-operative management in dMMR/MSI gastroesophageal adenocarcinomas: a case series and review of the literatureopens in new tab/window J.B. Demigné, F. Caillol, J. Guiramand, M. Heinisch, E. Mitry, B. Chanez, F. Benizri, B. Collineau, R. Mari, D. Dano, J.-E. Saadoun, C. de la Fouchardière

• Early-onset biliary tract cancers: clinical and molecular insightsopens in new tab/window C.D. O’Donnell, J. Nunnelee, A. Ness, P. Shah, O. Mosalem, U. Majeed, H. Babiker, J. Jones, J.S. Starr, M. Borad, N. Okano, A. Pirozzi, T.S. Bekaii-Saab, C. Wu, R.R. McWilliams, T.R. Halfdanarson, Z. Jin, L. Washburn, P. Starlinger, J. Heimbach, L.R. Roberts, G.J. Gores, F.-S. Ou, N.H. Tran

ESMO Real World Data and Digital Oncology

• Systematic identification of genomic nonresponse biomarkers to cancer therapiesopens in new tab/window J. Usset, J. de Ligt, S. Roerink, P. Roepman, E. Cuppen, F. Martínez-Jiménez

• Assessing clinical decision support system tools in precision oncology: piloting ring testing opens in new tab/windowV. Nygaard, S. Zhao, D. Tamborero, R. Rosenquist, A. Stenzinger, P. Roepman, J. Lehtiö, C.W. Yde, K. Rekker, C. Brodin, L. Verlingue, D. Bordin, J. Klajic, S.F. Haj Mohammad, L. Silwal-Pandit, A. Nilsen, M.R. Teixeira, A. Peixoto, S. Nakken, E. Hovig, A. Edsjö, H.G. Russnes on behalf of the PCM4EU Consortium

ESMO Rare Cancers

• Peptide receptor radionuclide therapy in olfactory neuroblastoma: a retrospective analysis of 177Lu-dotatate outcomes☆opens in new tab/window M.T. Cunha, L. Flynt, M. Sewastjanow-Silva, K. Wang, J. Phan, M. Chen, L.G. de Sousa, N. Akhave, M. Williams, E. Hanna, S.Y. Su, R. Ferrarotto

• Precision oncology in salivary gland cancer: molecular landscape, therapeutic advances and emerging strategiesopens in new tab/window S.W. Cheo, P.-J. Voon, Y. Honma, D.W.-T. Lim on behalf of ATLAS-HNCG (Asian Clinical Trials Network for Cancers Project-Head Neck Cancer Group)

ESMO affiliated journals

• Neurokinin pathway antagonists for vasomotor symptoms in women with breast cancer: focus on elinzanetant and fezolinetantopens in new tab/window Katarzyna Pogoda, Luca Arecco, Matteo Lambertini

• Toxicity profile and tolerability of immune checkpoint inhibitors for the treatment of early-stage breast cancer: a systematic review and meta-analysisopens in new tab/window Maria Inez Dacoregio, Caio Ernesto do Rego Castro, Isadora Mamede, Cainã Gonçalves Rodrigues, João Pedro Thimotheo Batista, Isabella Michelon, Paulo Zattar Ribeiro, José Reinaldo de Oliveira Junior, Renata Colombo Bonadio, Maysa Vilbert, Ricardo Lima Barros Costa

• Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challengesopens in new tab/window Zhiyu Liu, Yang Zhang, Man Xue, Zhaoxia Wang

• Immunotherapy for locally advanced head and neck squamous cell carcinoma: A reviewopens in new tab/window Robert Haddad, Makoto Tahara, Jean-Pascal Machiels, Theo Borgovan, Arindam Dhar, Kevin Harrington

• AI analysis of elastin staining sections reveals the biological implications of cancer-related fibrosis in small-sized lung adenocarcinomasopens in new tab/window Hitomi Kawai, Yasushi Yatabe, Akihiko Yoshizawa, Yasuhiro Sakai, Kohei Yamashita, Kazuhiro Hotta, Daisuke Matsubara, Masayuki Noguchi

• Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasmsopens in new tab/window Daniela Scattolin, Frank W.J. Heijboer, Giulia Pigato, Jules L. Derks, Ernst-Jan M. Speel, Tijmen van Weert, Daphne W. Dumoulin, Biancamaria Di Domenico, Lisa M. Hillen, Valentina Guarneri, Anne-Marie C. Dingemans, Giulia Pasello, Jan H. von der Thüsen

ESMO's Journal Portfolio

While diverse in nature and in content, these journals offer ESMO members and the oncology community a highly visible platform to publish important scientific studies, and a highly credible source for educational updates. Elsevier is the proud publisher of Annals of Oncology, Immuno-Oncology and Technology (IOTECH), ESMO Open, ESMO Gastrointestinal Oncology, ESMO Real World Data and Digital Oncology, ESMO Rare Cancers, and ESMO Affiliated Journals The Breast, Lung Cancer, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia.